Search research articles
Contact Us
Filters
Showing results (71-80 of 344) with videos related to
Page
of 35
Sort By:
BMC Cancer
|
November 17, 2020
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
Mashiro Okunaka, Daisuke Kotani, Ken Demachi, et al.
Annals of Gastroenterological Surgery
|
November 6, 2023
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
Masanori Tokunaga, Yukinori Kurokawa, Takeo Fukagawa, et al.
World Journal of Clinical Cases
|
December 3, 2020
Erratum: Author's Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (<i>World J Clin Cases</i> 2019; Aug 6; 7 (15): 1964-1977)
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
World Journal of Clinical Cases
|
August 20, 2019
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
Investigational New Drugs
|
February 26, 2011
Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
Kohei Shitara, Junko Ikeda, Tomoya Yokota, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 16, 2011
Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer
Kohei Shitara, Junko Ikeda, Chihiro Kondo, et al.
Expert Opinion on Biological Therapy
|
March 24, 2021
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
Jose Perez, Laia Garrigós, Maria Gion, et al.
Japanese Journal of Clinical Oncology
|
December 13, 2019
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
Konosuke Moritani, Yukihide Kanemitsu, Dai Shida, et al.
International Heart Journal
|
May 14, 2025
A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure
Takuro Imaoka, Kimi Sato, Shingo Sakashita, et al.
Japanese Journal of Clinical Oncology
|
August 7, 2007
Hepatic arterial infusion of oxaliplatin for a patient with hepatic metastases from colon cancer undergoing hemodialysis
Kohei Shitara, Masaki Munakata, Osamu Muto, et al.
Page
of 35
Search research articles
Search
Showing results (71-80 of 344) with videos related to
Sort By:
Page
of 35
BMC Cancer
|
November 17, 2020
Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer
Mashiro Okunaka, Daisuke Kotani, Ken Demachi, et al.
Annals of Gastroenterological Surgery
|
November 6, 2023
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
Masanori Tokunaga, Yukinori Kurokawa, Takeo Fukagawa, et al.
World Journal of Clinical Cases
|
December 3, 2020
Erratum: Author's Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (<i>World J Clin Cases</i> 2019; Aug 6; 7 (15): 1964-1977)
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
World Journal of Clinical Cases
|
August 20, 2019
HER2 heterogeneity is a poor prognosticator for HER2-positive gastric cancer
Akio Kaito, Takeshi Kuwata, Masanori Tokunaga, et al.
Investigational New Drugs
|
February 26, 2011
Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: analysis of 36 randomized trials
Kohei Shitara, Junko Ikeda, Tomoya Yokota, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 16, 2011
Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer
Kohei Shitara, Junko Ikeda, Chihiro Kondo, et al.
Expert Opinion on Biological Therapy
|
March 24, 2021
Trastuzumab deruxtecan in HER2-positive metastatic breast cancer and beyond
Jose Perez, Laia Garrigós, Maria Gion, et al.
Japanese Journal of Clinical Oncology
|
December 13, 2019
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
Konosuke Moritani, Yukihide Kanemitsu, Dai Shida, et al.
International Heart Journal
|
May 14, 2025
A Fatal Case of Immune Checkpoint Inhibitor-Associated Myocarditis with Severe Right Ventricular Failure
Takuro Imaoka, Kimi Sato, Shingo Sakashita, et al.
Japanese Journal of Clinical Oncology
|
August 7, 2007
Hepatic arterial infusion of oxaliplatin for a patient with hepatic metastases from colon cancer undergoing hemodialysis
Kohei Shitara, Masaki Munakata, Osamu Muto, et al.
Page
of 35